297 related articles for article (PubMed ID: 10523829)
1. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
Wong KS; Li YJ; Howard J; Ben-David Y
Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829
[TBL] [Abstract][Full Text] [Related]
2. Temporal order and functional analysis of mutations within the Fli-1 and p53 genes during the erythroleukemias induced by F-MuLV.
Howard JC; Yousefi S; Cheong G; Bernstein A; Ben-David Y
Oncogene; 1993 Oct; 8(10):2721-9. PubMed ID: 8378083
[TBL] [Abstract][Full Text] [Related]
3. p53-independent tumor growth and in vitro cell survival for F-MuLV-induced erythroleukemias.
Howard J; Ung Y; Adachi D; Ben-David Y
Cell Growth Differ; 1996 Dec; 7(12):1651-60. PubMed ID: 8959333
[TBL] [Abstract][Full Text] [Related]
4. Activation of the erythropoietin gene in the majority of F-MuLV-induced erythroleukemias results in growth factor independence and enhanced tumorigenicity.
Howard JC; Berger L; Bani MR; Hawley RG; Ben-David Y
Oncogene; 1996 Apr; 12(7):1405-15. PubMed ID: 8622856
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 expression in F-MuLV-induced erythroleukemias: a role for the anti-apoptotic action of Bcl-2 during tumor progression.
Howard JC; Li Q; Chu W; Zochodne B; Kapoor M; Ung Y; Rosen K; Ben-David Y
Oncogene; 2001 Apr; 20(18):2291-300. PubMed ID: 11402324
[TBL] [Abstract][Full Text] [Related]
6. FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts.
Pereira R; Quang CT; Lesault I; Dolznig H; Beug H; Ghysdael J
Oncogene; 1999 Feb; 18(8):1597-608. PubMed ID: 10102630
[TBL] [Abstract][Full Text] [Related]
7. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
[TBL] [Abstract][Full Text] [Related]
8. Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia.
Prasher JM; Elenitoba-Johnson KS; Kelley LL
Oncogene; 2001 May; 20(23):2946-55. PubMed ID: 11420707
[TBL] [Abstract][Full Text] [Related]
9. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.
Zhang L; Lemarchandel V; Romeo PH; Ben-David Y; Greer P; Bernstein A
Oncogene; 1993 Jun; 8(6):1621-30. PubMed ID: 8502483
[TBL] [Abstract][Full Text] [Related]
10. Insertional inactivation of the p53 gene during friend leukemia: a new strategy for identifying tumor suppressor genes.
Ben-David Y; Lavigueur A; Cheong GY; Bernstein A
New Biol; 1990 Nov; 2(11):1015-23. PubMed ID: 2101628
[TBL] [Abstract][Full Text] [Related]
11. p45(NFE2) is a negative regulator of erythroid proliferation which contributes to the progression of Friend virus-induced erythroleukemias.
Li YJ; Higgins RR; Pak BJ; Shivdasani RA; Ney PA; Archer M; Ben-David Y
Mol Cell Biol; 2001 Jan; 21(1):73-80. PubMed ID: 11113182
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus.
Ben David Y; Prideaux VR; Chow V; Benchimol S; Bernstein A
Oncogene; 1988 Aug; 3(2):179-85. PubMed ID: 2842714
[TBL] [Abstract][Full Text] [Related]
13. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
[TBL] [Abstract][Full Text] [Related]
14. Friend virus induced murine erythroleukaemia: the p53 locus.
Johnson P; Benchimol S
Cancer Surv; 1992; 12():137-51. PubMed ID: 1638545
[TBL] [Abstract][Full Text] [Related]
15. The role of Fli-1 in normal cell function and malignant transformation.
Truong AH; Ben-David Y
Oncogene; 2000 Dec; 19(55):6482-9. PubMed ID: 11175364
[TBL] [Abstract][Full Text] [Related]
16. Friend virus-induced erythroleukemias: a unique and well-defined mouse model for the development of leukemia.
Lee CR; Cervi D; Truong AH; Li YJ; Sarkar A; Ben-David Y
Anticancer Res; 2003; 23(3A):2159-66. PubMed ID: 12894591
[TBL] [Abstract][Full Text] [Related]
17. Resistance against Friend leukemia virus-induced leukemogenesis in DNA-dependent protein kinase (DNA-PK)-deficient scid mice associated with defective viral integration at the Spi-1 and Fli-1 site.
Hasegawa M; Yamaguchi S; Aizawa S; Ikeda H; Tatsumi K; Noda Y; Hirokawa K; Kitagawa M
Leuk Res; 2005 Aug; 29(8):933-42. PubMed ID: 15978944
[TBL] [Abstract][Full Text] [Related]
18. p53 transgenic mice: accelerated erythroleukemia induction by Friend virus.
Lavigueur A; Bernstein A
Oncogene; 1991 Dec; 6(12):2197-201. PubMed ID: 1766668
[TBL] [Abstract][Full Text] [Related]
19. 10A1 MuLV induces a murine leukemia that expresses hematopoietic stem cell markers by a mechanism that includes fli-1 integration.
Ott DE; Keller J; Rein A
Virology; 1994 Dec; 205(2):563-8. PubMed ID: 7975258
[TBL] [Abstract][Full Text] [Related]
20. Mutation of the Lyn tyrosine kinase delays the progression of Friend virus induced erythroleukemia without affecting susceptibility.
Subramanian A; Hegde S; Correll PH; Paulson RF
Leuk Res; 2006 Sep; 30(9):1141-9. PubMed ID: 16527351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]